375 related articles for article (PubMed ID: 38519650)
1. Tissue damaging toxins in snake venoms: mechanisms of action, pathophysiology and treatment strategies.
Bittenbinder MA; van Thiel J; Cardoso FC; Casewell NR; Gutiérrez JM; Kool J; Vonk FJ
Commun Biol; 2024 Mar; 7(1):358. PubMed ID: 38519650
[TBL] [Abstract][Full Text] [Related]
2. A Review of the Proteomic Profiling of African Viperidae and Elapidae Snake Venoms and Their Antivenom Neutralisation.
Offor BC; Muller B; Piater LA
Toxins (Basel); 2022 Oct; 14(11):. PubMed ID: 36355973
[TBL] [Abstract][Full Text] [Related]
3. Development of a high-throughput in vitro screening method for the assessment of cell-damaging activities of snake venoms.
Bittenbinder MA; Capinha L; Da Costa Pereira D; Slagboom J; van de Velde B; Casewell NR; Jennings P; Kool J; Vonk FJ
PLoS Negl Trop Dis; 2023 Aug; 17(8):e0011564. PubMed ID: 37590328
[TBL] [Abstract][Full Text] [Related]
4. Repurposed drugs and their combinations prevent morbidity-inducing dermonecrosis caused by diverse cytotoxic snake venoms.
Hall SR; Rasmussen SA; Crittenden E; Dawson CA; Bartlett KE; Westhorpe AP; Albulescu LO; Kool J; Gutiérrez JM; Casewell NR
Nat Commun; 2023 Dec; 14(1):7812. PubMed ID: 38097534
[TBL] [Abstract][Full Text] [Related]
5. Exploring the Utility of ssDNA Aptamers Directed against Snake Venom Toxins as New Therapeutics for Snakebite Envenoming.
Alomran N; Chinnappan R; Alsolaiss J; Casewell NR; Zourob M
Toxins (Basel); 2022 Jul; 14(7):. PubMed ID: 35878207
[TBL] [Abstract][Full Text] [Related]
6. Profiling the Murine Acute Phase and Inflammatory Responses to African Snake Venom: An Approach to Inform Acute Snakebite Pathology.
Alsolaiss J; Evans CA; Oluoch GO; Casewell NR; Harrison RA
Toxins (Basel); 2022 Mar; 14(4):. PubMed ID: 35448838
[TBL] [Abstract][Full Text] [Related]
7. Polymorphonuclear neutrophil leukocytes in snakebite envenoming.
Zuliani JP; Soares AM; Gutiérrez JM
Toxicon; 2020 Nov; 187():188-197. PubMed ID: 32956681
[TBL] [Abstract][Full Text] [Related]
8. Snake venom induced local toxicities: plant secondary metabolites as an auxiliary therapy.
Santhosh MS; Hemshekhar M; Sunitha K; Thushara RM; Jnaneshwari S; Kemparaju K; Girish KS
Mini Rev Med Chem; 2013 Jan; 13(1):106-23. PubMed ID: 22876950
[TBL] [Abstract][Full Text] [Related]
9. From Fangs to Pharmacology: The Future of Snakebite Envenoming Therapy.
Laustsen AH; Engmark M; Milbo C; Johannesen J; Lomonte B; Gutiérrez JM; Lohse B
Curr Pharm Des; 2016; 22(34):5270-5293. PubMed ID: 27339430
[TBL] [Abstract][Full Text] [Related]
10. Haemotoxic snake venoms: their functional activity, impact on snakebite victims and pharmaceutical promise.
Slagboom J; Kool J; Harrison RA; Casewell NR
Br J Haematol; 2017 Jun; 177(6):947-959. PubMed ID: 28233897
[TBL] [Abstract][Full Text] [Related]
11. Pathology-specific experimental antivenoms for haemotoxic snakebite: The impact of immunogen diversity on the in vitro cross-reactivity and in vivo neutralisation of geographically diverse snake venoms.
Alomran N; Alsolaiss J; Albulescu LO; Crittenden E; Harrison RA; Ainsworth S; Casewell NR
PLoS Negl Trop Dis; 2021 Aug; 15(8):e0009659. PubMed ID: 34407084
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological re-assessment of traditional medicinal plants-derived inhibitors as antidotes against snakebite envenoming: A critical review.
Puzari U; Fernandes PA; Mukherjee AK
J Ethnopharmacol; 2022 Jun; 292():115208. PubMed ID: 35314419
[TBL] [Abstract][Full Text] [Related]
13. The Search for Natural and Synthetic Inhibitors That Would Complement Antivenoms as Therapeutics for Snakebite Envenoming.
Gutiérrez JM; Albulescu LO; Clare RH; Casewell NR; Abd El-Aziz TM; Escalante T; Rucavado A
Toxins (Basel); 2021 Jun; 13(7):. PubMed ID: 34209691
[TBL] [Abstract][Full Text] [Related]
14. Monitoring Snake Venom-Induced Extracellular Matrix Degradation and Identifying Proteolytically Active Venom Toxins Using Fluorescently Labeled Substrates.
Bittenbinder MA; Bergkamp ND; Slagboom J; Bebelman JPM; Casewell NR; Siderius MH; Smit MJ; Kool J; Vonk FJ
Biology (Basel); 2023 May; 12(6):. PubMed ID: 37372050
[TBL] [Abstract][Full Text] [Related]
15. Procoagulant snake toxins: laboratory studies, diagnosis, and understanding snakebite coagulopathy.
Isbister GK
Semin Thromb Hemost; 2009 Feb; 35(1):93-103. PubMed ID: 19308897
[TBL] [Abstract][Full Text] [Related]
16. Unresolved issues in the understanding of the pathogenesis of local tissue damage induced by snake venoms.
Gutiérrez JM; Rucavado A; Escalante T; Herrera C; Fernández J; Lomonte B; Fox JW
Toxicon; 2018 Jun; 148():123-131. PubMed ID: 29698755
[TBL] [Abstract][Full Text] [Related]
17. Application of an Extracellular Matrix-Mimicking Fluorescent Polymer for the Detection of Proteolytic Venom Toxins.
Wachtel E; Bittenbinder MA; van de Velde B; Slagboom J; de Monts de Savasse A; Alonso LL; Casewell NR; Vonk FJ; Kool J
Toxins (Basel); 2023 Apr; 15(4):. PubMed ID: 37104232
[TBL] [Abstract][Full Text] [Related]
18. Trends in snakebite envenomation therapy: scientific, technological and public health considerations.
Gutiérrez JM; Lomonte B; León G; Rucavado A; Chaves F; Angulo Y
Curr Pharm Des; 2007; 13(28):2935-50. PubMed ID: 17979738
[TBL] [Abstract][Full Text] [Related]
19. The concept of Big Four: Road map from snakebite epidemiology to antivenom efficacy.
Gopal G; Muralidar S; Prakash D; Kamalakkannan A; Indhuprakash ST; Thirumalai D; Ambi SV
Int J Biol Macromol; 2023 Jul; 242(Pt 1):124771. PubMed ID: 37169043
[TBL] [Abstract][Full Text] [Related]
20. Inflammation and Oxidative Stress in Snakebite Envenomation: A Brief Descriptive Review and Clinical Implications.
Resiere D; Mehdaoui H; Neviere R
Toxins (Basel); 2022 Nov; 14(11):. PubMed ID: 36422976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
